Evidence of ARNI and SGLT2i association.

30 June 2021 (15:55 - 16:06)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Doctor Kieran Docherty

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail

ARNI and SGLT2i: start together or which first and when? Clinical case: start together.

Doctor J. Ferreira (Porto, PT)

Presentation thumbnail

ARNI and SGLT2i: start together or which first and when? Clinical case: start first.

Associate Professor M. Adamo (Brescia, IT)

Presentation thumbnail

HoT session – HFrEF treatment: not so easy as it seems, Part 1 - discussion.

Access the full session

Session thumbnail

HoT session – HFrEF treatment: not so easy as it seems, Part 1

The Event

Heart Failure 2021

30 June 2021 15:55 CET

You may be interested in

Congress Presentation

Efficacy of sodium-glucose cotransporter-2 inhibitors in heart failure patients treated with dual angiotensin receptor blocker-neprilysin inhibitor: an updated meta-analysis.

29 June 2021

Congress Presentation

Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction: data from SGLT2-I AMI PROTECT Registry

26 August 2023

Congress Presentation

Impact of early initiation of SGLT2 inhibitor on cardiovascular outcomes in diabetic patients with known atherosclerotic cardiovascular disease or risk factors: propensity score matched analysis

27 August 2021

Congress Session

Novel therapies in managing patients with cardiovascular-kidney-metabolic (CKM) syndrome and heart failure

4 April 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources